1. Radiofrequency ablation for treatment of hypersplenism: A feasible therapeutic option.
- Author
-
Martins GL, Bernardes JP, Rovella MS, Andrade RG, Viana PC, Herman P, Cerri GG, and Menezes MR
- Subjects
- Contrast Media, Humans, Hypersplenism diagnosis, Hypersplenism parasitology, Hypertension, Portal diagnosis, Hypertension, Portal parasitology, Liver Diseases, Parasitic complications, Liver Diseases, Parasitic diagnosis, Male, Middle Aged, Platelet Count, Predictive Value of Tests, Schistosomiasis mansoni complications, Schistosomiasis mansoni diagnosis, Thrombocytopenia diagnosis, Thrombocytopenia parasitology, Tomography, X-Ray Computed, Treatment Outcome, Catheter Ablation, Hypersplenism surgery, Liver Diseases, Parasitic parasitology, Schistosomiasis mansoni parasitology, Thrombocytopenia surgery
- Abstract
We present a case of a patient with hypersplenism secondary to portal hypertension due to hepato-splenic schistosomiasis, which was accompanied by severe and refractory thrombocytopenia. We performed spleen ablation and measured the total spleen and ablated volumes with contrast-enhanced computed tomography and volumetry. No major complications occurred, thrombocytopenia was resolved, and platelet levels remained stable, which allowed for early treatment of the patient's underlying disease. Previous work has shown that splenic radiofrequency ablation is an attractive alternative treatment for hypersplenism induced by liver cirrhosis. We aimed to contribute to the currently sparse literature evaluating the role of radiofrequency ablation (RFA) in the management of hypersplenism. We conclude that splenic RFA appears to be a viable and promising option for the treatment of hypersplenism.
- Published
- 2015
- Full Text
- View/download PDF